Cargando…
Blood and blood treatments
During 2020, COVID-19 or CoV2-SARS dominated the public and medical community's discourse, thus prompting a preponderance of COVID-driven research. Despite the many resulting studies, few new insights emerged regarding blood components and blood treatments, the focus of this chapter. The pandem...
Autores principales: | Gubler, K. Dean, Offner, Katie E., Higham, Michael C., Stephenson, Lynne Graves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548623/ http://dx.doi.org/10.1016/bs.seda.2021.09.002 |
Ejemplares similares
-
Age of blood: does it make a difference?
por: Offner, Patrick J
Publicado: (2004) -
Prehospital point of care testing of blood gases and electrolytes — an evaluation of IRMA
por: Prause, Gerhard, et al.
Publicado: (1997) -
Red Blood Cell-Derived Iron Alters Macrophage Function in COPD
por: Baker, James M., et al.
Publicado: (2021) -
Utilization of a topical autologous blood clot for treatment of pressure ulcers
por: Landau, Zvi, et al.
Publicado: (2022) -
Biomarker Exploration in Human Peripheral Blood Mononuclear Cells for Monitoring Sulforaphane Treatment Responses in Autism Spectrum Disorder
por: Liu, Hua, et al.
Publicado: (2020)